Related Experiment Video
Updated: May 27, 2026
08:42
Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
Antagonists of LRP6 regulate PTH-induced cAMP generation
Chenhui Shi1, Jun Li, Weishan Wang
1Shihezi Medical College, Shihezi University, Xinjiang, China.
Annals of the New York Academy of Sciences
|November 16, 2011
Summary
Sclerostin and DKK1, known Wnt antagonists, surprisingly enhance parathyroid hormone (PTH) signaling by interacting with LRP6. This discovery offers new therapeutic targets for bone diseases.
Area of Science:
- Biochemistry
- Cell Biology
- Endocrinology
Background:
- Low-density lipoprotein receptor-related protein 6 (LRP6) is a coreceptor for G protein-coupled receptors involved in cyclic adenosine monophosphate (cAMP) production.
- Sclerostin and Dickkopf-1 (DKK1) are extracellular proteins that antagonize Wnt signaling by binding to LRP6 and negatively regulate bone formation.
Purpose of the Study:
- To investigate the role of sclerostin and DKK1 in parathyroid hormone (PTH)-stimulated cAMP production.
- To explore the interaction between PTH, sclerostin, DKK1, and LRP6 in osteocytes.
Main Methods:
- In vitro assays measuring cAMP production.
- In vivo studies in mice to assess gene expression.
- Analysis of protein-ligand interactions.
Main Results:
- Sclerostin and DKK1 were found to inhibit PTH-stimulated cAMP production.
- PTH was observed to suppress sclerostin expression in mouse osteocytes.
- Sclerostin and DKK1 bind to LRP6 as antagonists, increasing LRP6 availability to facilitate PTH signaling in a positive-feedback loop.
Conclusions:
- Sclerostin and DKK1 have a previously unrecognized function in modulating PTH signaling.
- This interaction provides a novel mechanism explaining how sclerostin and DKK1 neutralization enhances bone formation.
- These findings suggest potential therapeutic strategies for skeletal diseases by targeting the sclerostin-DKK1-LRP6-PTH axis.
More Related Videos
Related Concept Videos
01:09GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:25cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:16Calmodulin-dependent Signaling
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...